MedTrace Logo

Role of Sclerotherapy in Treatment of Non-neoplastic Ovarian Cyst

NCT06399744 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-05-06

No results posted yet for this study

Summary

The aim of this study was to evaluate the role of sclerotherapy (injection of tetracycline or injection of Polidocanol - 95% hydroxypolyethoxydodecane and 5% ethanol -) in treatment of non-neoplastic ovarian cysts by, percutaneous trans-abdominal approach or trans-vaginal approach.

Conditions

  • Benign Ovarian Cyst

Interventions

PROCEDURE

sclerotherapy

injection of sclerosing agent (tetracycline or polidocanol) into ovarian cyst after aspiration of its contents

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Khaled Abdallah · Al-Azhar University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2024-01-30
Completion
2024-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06399744 on ClinicalTrials.gov